BioAdaptives Inc. (BDPT) Operating cash flow 2018–2025
BioAdaptives Inc. (BDPT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$516,025FY2025 · since FY2018: -$420,145 → -$516,025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$516,025 | -106.8% |
| FY2024 | -$249,517 | -11.5% |
| FY2023 | -$223,773 | +1.5% |
| FY2022 | -$227,259 | -43.2% |
| FY2021 | -$158,651 | -48.4% |
| FY2020 | -$106,889 | +36.4% |
| FY2019 | -$168,120 | +60.0% |
| FY2018 | -$420,145 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BDPT financial trends
BDPT RevenueBDPT Net incomeBDPT Net marginBDPT Gross profitBDPT Gross marginBDPT Operating incomeBDPT Operating marginBDPT Free cash flowBDPT Capital expendituresBDPT Return on equityBDPT Stock buybacksBDPT Dividends paidBDPT Total assetsBDPT Total liabilitiesBDPT Shareholders’ equityBDPT overview →